Hereditary polyneuropathy with optic atrophy due to PDXK variant leading to impaired Vitamin B6 metabolism
Authors:
- 28 April 2020
- journal article
- research article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 30 (7) , 583-589
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- PDXK mutations cause polyneuropathy responsive to pyridoxal 5′‐phosphate supplementationAnnals of Neurology, 2019
- Discovery of pyridoxal reductase activity as part of human vitamin B6 metabolismBiochimica et Biophysica Acta (BBA) - General Subjects, 2019
- Biallelic variant in AGTPBP1 causes infantile lower motor neuron degeneration and cerebellar atrophyAmerican Journal of Medical Genetics Part A, 2019
- An LC–MS/MS-Based Method for the Quantification of Pyridox(am)ine 5′-Phosphate Oxidase Activity in Dried Blood Spots from Patients with EpilepsyAnalytical Chemistry, 2017
- The B6 database: a tool for the description and classification of vitamin B6-dependent enzymatic activities and of the corresponding protein familiesBMC Bioinformatics, 2009
- Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5′-phosphate oxidaseHuman Molecular Genetics, 2005
- Genomic organization, tissue distribution and deletion mutation of human pyridoxine 5′‐phosphate oxidaseEuropean Journal of Biochemistry, 2004
- Pyridoxal Phosphate Enzymes: Mechanistic, Structural, and Evolutionary ConsiderationsAnnual Review of Biochemistry, 2004
- Human Pyridoxal PhosphataseJournal of Biological Chemistry, 2003
- Pyridoxal PhosphokinasesJournal of Biological Chemistry, 1961